PT3229828T - Insulin glargine/lixisenatide fixed ratio formulation - Google Patents

Insulin glargine/lixisenatide fixed ratio formulation

Info

Publication number
PT3229828T
PT3229828T PT158081778T PT15808177T PT3229828T PT 3229828 T PT3229828 T PT 3229828T PT 158081778 T PT158081778 T PT 158081778T PT 15808177 T PT15808177 T PT 15808177T PT 3229828 T PT3229828 T PT 3229828T
Authority
PT
Portugal
Prior art keywords
fixed ratio
insulin glargine
ratio formulation
lixisenatide fixed
lixisenatide
Prior art date
Application number
PT158081778T
Other languages
Portuguese (pt)
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of PT3229828T publication Critical patent/PT3229828T/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
PT158081778T 2015-11-10 2015-12-10 Insulin glargine/lixisenatide fixed ratio formulation PT3229828T (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15193940 2015-11-10

Publications (1)

Publication Number Publication Date
PT3229828T true PT3229828T (en) 2023-06-29

Family

ID=54542010

Family Applications (1)

Application Number Title Priority Date Filing Date
PT158081778T PT3229828T (en) 2015-11-10 2015-12-10 Insulin glargine/lixisenatide fixed ratio formulation

Country Status (2)

Country Link
EA (1) EA039114B1 (en)
PT (1) PT3229828T (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011202239C1 (en) * 2010-05-19 2017-03-16 Sanofi Long-acting formulations of insulins
EP2389945A1 (en) * 2010-05-28 2011-11-30 Sanofi-Aventis Deutschland GmbH Pharmaceutical composition comprising AVE0010 and insulin glargine
JP6438944B2 (en) * 2013-06-17 2018-12-19 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Insulin glargine / lixisenatide fixed ratio formulation

Also Published As

Publication number Publication date
EA201791296A1 (en) 2018-10-31
EA039114B1 (en) 2021-12-06

Similar Documents

Publication Publication Date Title
HRP20190557T1 (en) Insulin glargine/lixisenatide fixed ratio formulation
IL248350A0 (en) Rapid-acting insulin compositions
ZA201800511B (en) Rapid-acting insulin compositions
RS63174B1 (en) Rapid-acting insulin compositions
IL252803B (en) Insulin glargine/lixisenatide fixed ratio formulation
PL3518892T3 (en) Pharmaceutical formulation comprising an insulin compound
PT3229828T (en) Insulin glargine/lixisenatide fixed ratio formulation
TH1501007506A (en) Fixed ratio insulin glargine/lixisinatide formulation.